| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.0M | -76.2% |
| Cost of Revenue | $78K | -95.5% |
| R&D Expense | $10.4M | -64.6% |
| SG&A Expense | $10.5M | -27.0% |
| Operating Income | -$18.9M | +48.7% |
| Income Tax | $0 | — |
| Net Income | -$8.3M | +69.9% |
| EPS (Basic) | -$0.27 | +74.3% |
| EPS (Diluted) | -$0.27 | +77.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $11.0M | -61.2% |
| Accounts Receivable | $453K | -64.1% |
| Inventory | $106K | -95.2% |
| Current Assets | $13.2M | -62.0% |
| Total Assets | $18.3M | -59.4% |
| Current Liabilities | $7.7M | -71.5% |
| Stockholders' Equity | $9.1M | -38.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$19.1M | +44.5% |
| Capital Expenditures | $0 | -100.0% |
| Investing Cash Flow | $18.0M | +1647.5% |
| Financing Cash Flow | -$16.3M | -179.8% |
| Free Cash Flow | -$19.1M | +44.6% |